Uterine polyps should be removed when they cause abnormal bleeding, when you are trying to conceive, or when features of the polyp raise concern about precancer or cancer. For asymptomatic premenopausal women with small polyps, watchful waiting is a reasonable alternative, since some polyps shrink or disappear on their own. Postmenopausal women, even without symptoms, face a higher risk that polyps harbor malignant cells, which shifts the calculus toward removal. The decision hinges on a handful of personal risk factors that are worth understanding in detail.
The Core Guideline
An evidence-based practice guide published in the journal Climacteric captures the general consensus: conservative management is an option for asymptomatic premenopausal and postmenopausal women, while polypectomy is recommended for all women with abnormal uterine bleeding.1PubMed. To treat or not to treat? An evidence-based practice guide for the management of endometrial polyps That sounds simple, but the word “option” does a lot of work. In practice, clinicians weigh a cluster of risk factors before deciding whether to watch and wait or schedule a procedure. Bleeding is the clearest trigger, but it is not the only one.
Abnormal Bleeding and Symptom Relief
Heavy periods, bleeding between cycles, and postmenopausal spotting are the most common reasons polyps get removed. These growths in the uterine lining can disrupt normal shedding and produce unpredictable, sometimes heavy bleeding.2PubMed Central. Endometrial polyps: Pathogenesis, sequelae and treatment Many polyps cause no symptoms at all, but when they do, the bleeding can be disruptive enough to affect daily life. A study tracking outcomes after office-based polyp removal found that symptoms resolved or decreased considerably in about two-thirds of premenopausal patients and in over 90% of postmenopausal patients.3PubMed Central. Effectiveness and patient satisfaction with office hysteroscopic polypectomy in patients with symptomatic endometrial polyps If you are dealing with irregular or heavy bleeding that imaging has linked to a polyp, removal is the standard recommendation regardless of your age or menopausal status.
Cancer Risk and What Raises It
Most uterine polyps are benign. A review of over 1,000 polypectomy specimens found that roughly 95% of polyps were benign, with about 1.3% harboring endometrial cancer and another 0.5% showing atypical hyperplasia, a precancerous change.4PubMed. Risk and predictors of malignancy in women with endometrial polyps Those numbers are reassuring for most women, but certain characteristics push the risk higher.
A retrospective study of 725 patients in South Korea found that about 7% had premalignant or malignant changes within their polyps. The strongest predictor was being postmenopausal, which carried roughly an eightfold higher odds of malignancy compared with premenopausal status. Abnormal bleeding was the next biggest flag, followed by obesity, having multiple polyps, and never having been pregnant.5PubMed. The risk factors for premalignant and malignant endometrial polyps in premenopausal and postmenopausal women and trends over the past decade That same large pathology review confirmed that menopausal status was the only clinical factor significantly associated with atypical hyperplasia or cancer. Among postmenopausal women with bleeding, the rate of cancer or atypical hyperplasia was about 4%, roughly four times the rate in premenopausal women with bleeding.4PubMed. Risk and predictors of malignancy in women with endometrial polyps
Polyp size and endometrial thickness also matter. Research tracking malignancy risk found that polyps measuring 2.25 cm or longer, and an endometrial lining thicker than 11 mm, were each associated with substantially higher odds of malignancy.6PubMed Central. Malignancy risk factors based on endometrial polyp The same study flagged elevated fasting blood glucose and elevated C-reactive protein as additional risk markers. Taken together, the picture is clear: if you are postmenopausal, have abnormal bleeding, carry excess weight, have elevated blood sugar or inflammatory markers, or have a large or thick polyp, the case for removal is strongest because the chance of hidden malignancy is meaningfully higher.
When Watching and Waiting Makes Sense
Not every polyp needs to come out. Smaller polyps in younger, premenopausal women sometimes resolve without treatment, and this is where conservative management enters the conversation. A study following women scheduled for surgery found that about 23% of those re-evaluated before their procedure had spontaneous polyp regression. Being under 45, being premenopausal, and having polyps smaller than 2 cm were all associated with this natural disappearance.7PubMed Central. Endometrial polyps: Is the prediction of spontaneous regression possible?
Size turns out to be the strongest predictor of whether a polyp will shrink on its own. A separate analysis broke down regression rates by millimeter brackets and found that polyps under 10 mm regressed at rates between 12% and 17%, while polyps 10 mm or larger almost never did. Among polyps over 20 mm, the regression rate was zero.8PubMed Central. Predictive factors of spontaneously regressed uterine endometrial polyps during the waiting period before hysteroscopic polypectomy If you are premenopausal, your polyp is small, and you are not experiencing bothersome symptoms, your doctor may reasonably suggest a follow-up ultrasound in a few months rather than jumping straight to a procedure. The polyp might be gone by then.
That said, watchful waiting comes with a responsibility: you need to actually follow up. A polyp that persists, grows, or starts causing bleeding shifts into the “should be removed” category. Ignoring it indefinitely is not the same as monitored conservative management.
Polyps and Fertility
If you are trying to get pregnant and a polyp has been found, removal is generally recommended regardless of whether the polyp is causing symptoms. Polyps can interfere with implantation, and there is evidence that removing them improves pregnancy rates. A study of previously infertile women found that hysteroscopic polypectomy improved fertility and increased pregnancy rates irrespective of polyp size or number when no other cause of infertility could be identified.9PubMed. Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps The benefit appears to be especially clear for women with a history of recurrent pregnancy loss.10PubMed. Fertility outcomes after hysteroscopic removal of intrauterine leiomyomas and polyps
For women undergoing IVF, the evidence is even more directly actionable. Polyps found on pre-IVF evaluation are routinely removed, and the data supports this practice. One study of women with repeated IVF failures found that those with endometrial pathology, predominantly polyps, who had the issue corrected showed significantly improved implantation and clinical pregnancy rates afterward.11PubMed. Hysteroscopic findings in women with recurrent IVF failures and the effect of correction of hysteroscopic findings on subsequent pregnancy rates A retrospective study comparing hysteroscopic polypectomy with simple curettage before IVF embryo transfer found that the hysteroscopic approach produced a pregnancy rate of about 68% versus 51% in the curettage group after the first embryo transfer, suggesting that thorough, targeted polyp removal makes a measurable difference.12PubMed Central. Pregnancy Rates after Hysteroscopic Endometrial Polypectomy versus Endometrial Curettage Polypectomy: A Retrospective Study
How Polyps Are Diagnosed
Before you can decide whether to remove a polyp, you need to know it is there and how big it is. Most polyps are discovered incidentally during imaging for other reasons, or picked up when investigating abnormal bleeding. The standard first-line tool is transvaginal ultrasound, which has a sensitivity of about 62% and specificity of about 73% for detecting polyps. Saline infusion sonohysterography, where a small amount of saline is flushed into the uterine cavity during the ultrasound, performs better, with sensitivity and specificity both around 87%. Hysteroscopy, in which a small camera is inserted directly into the uterus, is the most accurate method, with sensitivity around 92%.13PubMed Central. Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography, and hysteroscopy in evaluating the endometrial polyps in women with abnormal uterine bleeding
In fertility workups specifically, transvaginal ultrasound and saline sonohysterography have both been found reliable for detecting the hyperechoic polyps that commonly show up in these patients.14Journal of Biological and Allied Health Sciences. Comparison of Transvaginal Ultrasound and Saline Sonography Accuracy for Detection of Endometrial Polyps In practice, a polyp suspected on ultrasound is often confirmed and removed in the same hysteroscopy session, combining the diagnostic and therapeutic steps.
The Removal Procedure
Hysteroscopic polypectomy is the gold standard for removing uterine polyps. A thin scope is passed through the cervix into the uterus, the polyp is identified visually, and it is removed using small instruments, a loop, or a tissue-removal device. The tissue goes to pathology, which is the only way to definitively rule out precancerous or cancerous changes.
A growing body of evidence supports doing this in an office setting rather than an operating room for straightforward cases. A systematic review found that office hysteroscopy had a procedure-completion rate of about 95% with a complication rate of only 0.6%. Pain scores were low, most procedures were done without anesthesia, and recovery was faster.15PubMed Central. Office vs. Operating Room Hysteroscopy for Intrauterine Pathology: A Systematic Review of Clinical and Patient-Centered Outcomes An individual center’s comparison found that office patients spent roughly 2.5 hours total versus nearly 5.5 hours for operating-room patients, and required fewer pre-procedure tests.16Obstetrics & Gynecology. Office versus Operating Room Hysteroscopy: A Comparison of Outcomes and Resource Utilization The operating room is still necessary for larger polyps, cervical stenosis that prevents easy access, or cases where fibroids are also present. About a third of office procedures in one series ultimately required an operating-room follow-up for these reasons.16Obstetrics & Gynecology. Office versus Operating Room Hysteroscopy: A Comparison of Outcomes and Resource Utilization
Regarding technique, a study comparing a manual hysteroscopic tissue removal device against conventional resection found no difference in pregnancy rates, clinical pregnancy rates, or miscarriage rates following the first embryo transfer in IVF patients. The timing from polypectomy to embryo transfer also did not seem to matter.17PubMed Central. No differences in IVF pregnancy outcomes following hysteroscopic polypectomy using a manual hysteroscopic tissue removal device versus conventional resection So while the technique your surgeon uses may vary, it is the completeness of polyp removal rather than the specific instrument that appears to determine outcomes.
Polyps and Tamoxifen
Women taking tamoxifen for breast cancer face a distinct set of considerations. Tamoxifen has estrogen-like effects on the uterine lining and significantly raises the risk of developing polyps. The incidence of polyps in tamoxifen users has been reported between 8% and 36%, compared with up to 10% in untreated women, and tamoxifen-related polyps tend to be substantially larger.18PubMed Central. The effect of tamoxifen on the genital tract More importantly, these polyps carry a malignant-change rate of 3% to nearly 11%, far higher than the rate in the general population.18PubMed Central. The effect of tamoxifen on the genital tract
A large Korean cohort study found that tamoxifen use was independently associated with roughly a fourfold increased risk of developing endometrial polyps, a nearly sixfold increased risk of endometrial hyperplasia, and a nearly fourfold increased risk of endometrial cancer.19JAMA Network Open. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer Because of this elevated risk profile, polyps found in tamoxifen users are generally removed promptly rather than monitored. These polyps are also reported to be more difficult to resect during hysteroscopy because of structural differences in the tissue.
After Removal: Recurrence and How to Reduce It
Polyps can come back. One study following women after hysteroscopic polypectomy found that 43% had a recurrence confirmed on follow-up hysteroscopy. Having multiple polyps at the initial procedure and a longer follow-up interval were the strongest predictors of recurrence.20PubMed Central. Factors Influencing the Recurrence Potential of Benign Endometrial Polyps after Hysteroscopic Polypectomy That 43% figure comes from a study with relatively long follow-up, however. Other data puts the recurrence rate much lower: about 8% of reproductive-age patients in one analysis, with a median time to recurrence of roughly 3.5 years.21Medical Science Monitor. Comprehensive Analysis of Risk Factors for Recurrence in Women of Reproductive Age Undergoing Hysteroscopic Polypectomy A large clinicopathologic analysis of over 1,900 polyps found that recurrence occurred in about 6% of cases and, reassuringly, that a recurrent polyp did not carry an increased risk of malignancy compared with an initial polyp.22Human Pathology. The significance of recurrence in endometrial polyps: a clinicopathologic analysis
The wide range in reported recurrence rates reflects differences in how aggressively researchers looked for new polyps and how long they followed patients. But the reassuring takeaway is that a recurrent polyp is not a sign that something has gone wrong or that cancer risk has increased. It just means the underlying hormonal or tissue conditions that produced the first polyp are still at work.
There is good evidence that a levonorgestrel-releasing intrauterine device (the hormonal IUD often known by brand names) can substantially reduce the odds of recurrence. A retrospective study of premenopausal patients found that polyp recurrence within three years was about 3.5% in women who had the device placed after polypectomy versus about 16% in those who did not.23PubMed. Prevention of Benign Endometrial Polyp Recurrence Using a Levonorgestrel-releasing Intrauterine System in Premenopausal Patients A separate pilot study using direct hysteroscopic visualization confirmed that polyps were present in 80% of the control group at a second-look procedure but only 37% of the hormonal IUD group, and suggested the device may even cause existing polyps to regress.24PubMed. The Role of the Mirena Intrauterine Device in the Management of Endometrial Polyps: A Pilot Study If you have had a polyp removed and want to reduce the chance of another one, discussing a hormonal IUD with your gynecologist is a practical step, especially if you also want contraception or relief from heavy periods.
Hormone Replacement Therapy and Polyp Formation
For postmenopausal women considering or already using hormone replacement therapy, the type of HRT matters. A study using multiple regression analysis found that the formulation of HRT, late menopause, and obesity all independently increased the likelihood of developing endometrial polyps.25PubMed. The role of hormone replacement therapy in endometrial polyp formation Interestingly, while certain HRT regimens may promote polyp growth, other research found that HRT may cause existing polyps to involute by decreasing cell proliferation and stimulating cell death within the polyp tissue.26PubMed. Effect of previous hormone replacement therapy on endometrial polyps during menopause The picture is not entirely straightforward, which is why postmenopausal women on HRT who develop polyps are often advised to have them removed and sent for pathology rather than relying on the assumption that the polyp is harmless.
Putting It All Together for Different Situations
Because the research covers a range of clinical scenarios, it helps to think about which situation matches yours:
- Premenopausal, no symptoms, small polyp: Watchful waiting is reasonable. A follow-up ultrasound in three to six months can check whether the polyp has shrunk or resolved. If it persists or grows, removal is prudent.
- Any age, abnormal bleeding: Removal is the standard recommendation, both to relieve symptoms and to allow pathology testing. Symptom improvement rates after polypectomy are high.
- Postmenopausal: Even without bleeding, the risk of precancerous or cancerous changes is meaningfully higher. Many clinicians lean toward removal, especially if other risk factors like obesity or diabetes are present.
- Trying to conceive: Removal is recommended regardless of symptoms. The evidence supports improved pregnancy rates after polypectomy, both for natural conception and for IVF.
- On tamoxifen: Polyps should generally be removed promptly due to the elevated malignancy risk and the unusual tissue characteristics of tamoxifen-related polyps.
- Large polyp or multiple polyps: Larger polyps do not regress spontaneously and carry higher malignancy risk. Multiple polyps are associated with both higher malignancy odds and higher recurrence rates. Removal is favored.
The bottom-line reality is that uterine polyps sit on a spectrum from completely harmless to potentially dangerous, and the factors that determine where any given polyp falls on that spectrum are well studied. Your age, menopausal status, symptoms, polyp size, number of polyps, body weight, medication history, and fertility goals all factor into the decision. A conversation with your gynecologist about your specific combination of risk factors will be more useful than any general rule, but the evidence gives a clear framework for when to act and when waiting is reasonable.